Stock listing
A41AKJ Stock Price, News, Filings & Events — Nextcure, Inc.
Selected listing: A41AKJ · LSX · EUR · DE
This page tracks Nextcure, Inc.'s A41AKJ:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A41AKJ:LSX. A41AKJ:LSX is the stock-level entry point for investors researching Nextcure, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A41AKJ:LSX
- Asset type
- Stock
- Market cap
- $32.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSX
- Currency
- EUR
Nextcure, Inc. A41AKJ:LSX stock context
This page tracks Nextcure, Inc.'s A41AKJ:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A41AKJ:LSX. A41AKJ:LSX is the stock-level entry point for investors researching Nextcure, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Nextcure, Inc.
NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results
August 6, 2026
NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy
July 14, 2026
NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecol...
June 4, 2026
NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026
June 1, 2026
NextCure Provides Business Update and Reports First Quarter 2026 Financial Results
May 7, 2026
Research Nextcure, Inc.
Nextcure, Inc. investor report
Review AI stock analysis and investor report context for A41AKJ:LSX.
Nextcure, Inc. company profile
View the public company page for Nextcure, Inc. on 6ix.
Nextcure, Inc. news
Read company news and market updates connected to Nextcure, Inc..
Nextcure, Inc. investor events
Find investor webinars, events, and replay context for Nextcure, Inc..
Alternate listings
NXTC:NASDAQ
US · USD
Alternate listing for Nextcure, Inc.; the primary context on this page is A41AKJ:LSX.
NXTC:BOATS
US · USD
Alternate listing for Nextcure, Inc.; the primary context on this page is A41AKJ:LSX.
2US0:FWB
DE · EUR
Alternate listing for Nextcure, Inc.; the primary context on this page is A41AKJ:LSX.
2US0:GETTEX
DE · EUR
Alternate listing for Nextcure, Inc.; the primary context on this page is A41AKJ:LSX.
A41AKJ:LS
DE · EUR
Alternate listing for Nextcure, Inc.; the primary context on this page is A41AKJ:LSX.
2US0:MUN
DE · EUR
Alternate listing for Nextcure, Inc.; the primary context on this page is A41AKJ:LSX.